Genetic Association Between Schizophrenia and Cortical Brain Surface Area and Thickness.


Journal

JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550

Informations de publication

Date de publication:
01 09 2021
Historique:
pubmed: 24 6 2021
medline: 19 1 2022
entrez: 23 6 2021
Statut: ppublish

Résumé

Schizophrenia is a complex heritable disorder associated with many genetic variants, each with a small effect. While cortical differences between patients with schizophrenia and healthy controls are consistently reported, the underlying molecular mechanisms remain elusive. To investigate the extent of shared genetic architecture between schizophrenia and brain cortical surface area (SA) and thickness (TH) and to identify shared genomic loci. Independent genome-wide association study data on schizophrenia (Psychiatric Genomics Consortium and CLOZUK: n = 105 318) and SA and TH (UK Biobank: n = 33 735) were obtained. The extent of polygenic overlap was investigated using MiXeR. The specific shared genomic loci were identified by conditional/conjunctional false discovery rate analysis and were further examined in 3 independent cohorts. Data were collected from December 2019 to February 2021, and data analysis was performed from May 2020 to February 2021. The primary outcomes were estimated fractions of polygenic overlap between schizophrenia, total SA, and average TH and a list of functionally characterized shared genomic loci. Based on genome-wide association study data from 139 053 participants, MiXeR estimated schizophrenia to be more polygenic (9703 single-nucleotide variants [SNVs]) than total SA (2101 SNVs) and average TH (1363 SNVs). Most SNVs associated with total SA (1966 of 2101 [93.6%]) and average TH (1322 of 1363 [97.0%]) may be associated with the development of schizophrenia. Subsequent conjunctional false discovery rate analysis identified 44 and 23 schizophrenia risk loci shared with total SA and average TH, respectively. The SNV associations of shared loci between schizophrenia and total SA revealed en masse concordant association between the discovery and independent cohorts. After removing high linkage disequilibrium regions, such as the major histocompatibility complex region, the shared loci were enriched in immunologic signature gene sets. Polygenic overlap and shared loci between schizophrenia and schizophrenia-associated regions of interest for SA (superior frontal and middle temporal gyri) and for TH (superior temporal, inferior temporal, and superior frontal gyri) were also identified. This study demonstrated shared genetic loci between cortical morphometry and schizophrenia, among which a subset are associated with immunity. These findings provide an insight into the complex genetic architecture and associated with schizophrenia.

Identifiants

pubmed: 34160554
pii: 2781372
doi: 10.1001/jamapsychiatry.2021.1435
pmc: PMC8223140
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1020-1030

Références

Nat Genet. 2016 May;48(5):481-7
pubmed: 27019110
Biol Psychiatry. 2019 Oct 1;86(7):536-544
pubmed: 31171358
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
Mol Psychiatry. 2020 Nov;25(11):3053-3065
pubmed: 30279459
Hum Mol Genet. 2018 Oct 15;27(20):3641-3649
pubmed: 30124842
Mol Psychiatry. 2015 Feb;20(2):207-14
pubmed: 24468824
Mol Psychiatry. 2016 Dec;21(12):1696-1709
pubmed: 26903267
Nat Rev Neurol. 2020 Jul;16(7):366-379
pubmed: 32528109
Nat Commun. 2019 Jun 3;10(1):2417
pubmed: 31160569
Am J Psychiatry. 2003 Apr;160(4):636-45
pubmed: 12668349
Br J Psychiatry. 2020 May;216(5):280-283
pubmed: 32000869
Science. 2016 Feb 26;351(6276):933-9
pubmed: 26822608
Biometrika. 2011 Mar;98(1):199-214
pubmed: 23049127
Eur J Hum Genet. 2009 Mar;17(3):287-94
pubmed: 18854867
Nat Genet. 2006 Sep;38(9):1032-7
pubmed: 16906163
Science. 2020 Mar 20;367(6484):
pubmed: 32193296
JAMA Psychiatry. 2019 Jul 1;76(7):739-748
pubmed: 30969333
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Neurobiol Aging. 2019 Apr;76:115-124
pubmed: 30711674
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
Mol Psychiatry. 2016 Apr;21(4):547-53
pubmed: 26033243
JAMA Psychiatry. 2017 Oct 1;74(10):1065-1075
pubmed: 28746715
Psychol Med. 1998 May;28(3):655-63
pubmed: 9626721
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Sci Rep. 2019 Nov 8;9(1):16342
pubmed: 31704962
Nat Neurosci. 2019 Mar;22(3):374-385
pubmed: 30718903
Schizophr Bull. 2019 Oct 24;45(6):1209-1217
pubmed: 30597053
Mol Psychiatry. 2021 Aug;26(8):4055-4065
pubmed: 31792363
Mol Psychiatry. 2018 Jun;23(6):1512-1520
pubmed: 28507318
Schizophr Bull. 2016 Sep;42(5):1167-75
pubmed: 27056715
Hum Brain Mapp. 2021 Jun 1;42(8):2546-2555
pubmed: 33638594
Mol Psychiatry. 2017 Aug;22(8):1224
pubmed: 28220043
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Lancet Psychiatry. 2015 Mar;2(3):258-270
pubmed: 26359903
Arch Gen Psychiatry. 2003 Dec;60(12):1187-92
pubmed: 14662550
Nat Rev Neurosci. 2017 Jun;18(6):335-346
pubmed: 28469276
Genome Res. 2012 Sep;22(9):1790-7
pubmed: 22955989
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
Nat Neurosci. 2019 Oct;22(10):1617-1623
pubmed: 31551603
Am J Hum Genet. 2019 Sep 5;105(3):456-476
pubmed: 31402091
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
Nat Genet. 2018 Mar;50(3):381-389
pubmed: 29483656
Nat Rev Neurol. 2018 Oct;14(10):577-589
pubmed: 30171200
Nat Genet. 2018 Aug;50(8):1112-1121
pubmed: 30038396
Nat Genet. 2019 Feb;51(2):245-257
pubmed: 30643258
Biol Psychiatry. 2019 Oct 1;86(7):499-501
pubmed: 31521208
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Nat Genet. 2018 Jul;50(7):912-919
pubmed: 29942086
Schizophr Res. 2013 Dec;151(1-3):226-8
pubmed: 24239283
Mol Psychiatry. 2018 Oct;23(10):1974-1980
pubmed: 29203849
Schizophr Bull. 2018 Jun 6;44(4):854-864
pubmed: 29136250
Front Genet. 2019 Aug 02;10:703
pubmed: 31428135
Am J Hum Genet. 2013 Feb 7;92(2):197-209
pubmed: 23375658
Nature. 1990 Feb 1;343(6257):461-3
pubmed: 2105469
PLoS Genet. 2020 May 19;16(5):e1008612
pubmed: 32427991
Brain Behav Immun. 2015 Aug;48:195-204
pubmed: 25882911
Nat Genet. 2019 Dec;51(12):1670-1678
pubmed: 31740837
JAMA Psychiatry. 2020 May 1;77(5):503-512
pubmed: 31913414
Schizophr Bull. 2014 Jan;40(1):13-7
pubmed: 24319118
Nat Rev Neurosci. 2017 Dec;18(12):727-740
pubmed: 29070826
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
J Comp Neurol. 1989 Aug 22;286(4):442-55
pubmed: 2778101
Mol Psychiatry. 2015 Dec;20(12):1588-95
pubmed: 25687773
Biol Psychiatry. 2018 Nov 1;84(9):644-654
pubmed: 29960671
Nat Neurosci. 2016 Mar;19(3):420-431
pubmed: 26854805
Int J Obes (Lond). 2020 Jul;44(7):1487-1496
pubmed: 32433603
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4441-6
pubmed: 18332434

Auteurs

Weiqiu Cheng (W)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Oleksandr Frei (O)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Dennis van der Meer (D)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
School of Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.

Yunpeng Wang (Y)

Centre for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway.

Kevin S O'Connell (KS)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Yunhan Chu (Y)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Shahram Bahrami (S)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Alexey A Shadrin (AA)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Dag Alnæs (D)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Guy F L Hindley (GFL)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Psychosis Studies, Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, United Kingdom.

Aihua Lin (A)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Naz Karadag (N)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Chun-Chieh Fan (CC)

Population Neuroscience and Genetics Lab, University of California, San Diego, La Jolla.
Center for Human Development, University of California, San Diego, La Jolla.

Lars T Westlye (LT)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.

Tobias Kaufmann (T)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.

Espen Molden (E)

Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
Department of Pharmacy, University of Oslo, Oslo, Norway.

Anders M Dale (AM)

Department of Radiology, University of California, San Diego, La Jolla.
Department of Psychiatry, University of California, San Diego, La Jolla.
Department of Neurosciences, University of California San Diego, La Jolla.

Srdjan Djurovic (S)

Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway.

Olav B Smeland (OB)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Ole A Andreassen (OA)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH